Cinacalcet Appears Safe, Effective for Children With SHPT
Medical Health News,
Share this content: In a small study, more than half of pediatric patients receiving cinacalcet experienced a 30% or greater…
Share this content: In a small study, more than half of pediatric patients receiving cinacalcet experienced a 30% or greater…
Cinacalcet is approved in Europe for treatment of secondary hyperparathyroidism (SHPT) in children aged 3 years and older on…